Skip to main content

Main menu

  • Home
  • Current Issue
  • Ahead of Print
  • Past Issues
  • Info for
    • Authors
    • Print Subscriptions
  • About
    • About the Journal
    • About the Academy
    • Editorial Board
  • Feedback
  • Alerts
  • AAPL

User menu

  • Alerts

Search

  • Advanced search
Journal of the American Academy of Psychiatry and the Law
  • AAPL
  • Alerts
Journal of the American Academy of Psychiatry and the Law

Advanced Search

  • Home
  • Current Issue
  • Ahead of Print
  • Past Issues
  • Info for
    • Authors
    • Print Subscriptions
  • About
    • About the Journal
    • About the Academy
    • Editorial Board
  • Feedback
  • Alerts
Research ArticleAnalysis and Commentary

The Evolving Standard of Care for Autoimmune Neuropsychiatric Illness

Cynthia He, Nathaniel Morris, Dale McNiel and Renee Binder
Journal of the American Academy of Psychiatry and the Law Online June 2024, 52 (2) 225-234; DOI: https://doi.org/10.29158/JAAPL.240033-24
Cynthia He
Dr. He is a Forensic Psychiatry Fellow, Dr. Morris is an Assistant Professor of Clinical Psychiatry, Dr. McNiel is a Professor Emeritus of Clinical Psychology, and Dr. Binder is a Professor of Psychiatry and Director of the Psychiatry and the Law Program, University of California, San Francisco, San Francisco, CA.
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nathaniel Morris
Dr. He is a Forensic Psychiatry Fellow, Dr. Morris is an Assistant Professor of Clinical Psychiatry, Dr. McNiel is a Professor Emeritus of Clinical Psychology, and Dr. Binder is a Professor of Psychiatry and Director of the Psychiatry and the Law Program, University of California, San Francisco, San Francisco, CA.
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dale McNiel
Dr. He is a Forensic Psychiatry Fellow, Dr. Morris is an Assistant Professor of Clinical Psychiatry, Dr. McNiel is a Professor Emeritus of Clinical Psychology, and Dr. Binder is a Professor of Psychiatry and Director of the Psychiatry and the Law Program, University of California, San Francisco, San Francisco, CA.
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Renee Binder
Dr. He is a Forensic Psychiatry Fellow, Dr. Morris is an Assistant Professor of Clinical Psychiatry, Dr. McNiel is a Professor Emeritus of Clinical Psychology, and Dr. Binder is a Professor of Psychiatry and Director of the Psychiatry and the Law Program, University of California, San Francisco, San Francisco, CA.
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Tables

    • View popup
    Table 1

    Risk Stratification and Diagnostic Criteria for Autoimmune Encephalitis/Psychosis

    Screening Tool: Antibody Prevalence in Epilepsy and Encephalopathy (APE2) score (Dubey 2018)14
    +1 point each:
    • • New-onset, rapidly progressive mental status changes (1–6 weeks) or new-onset seizures (past year)

    • • Neuropsychiatric symptoms

    • • Autonomic dysfunction

    +2 points each:
    • • Viral prodrome

    • • Facial dyskinesias (if no faciobrachial dystonic seizures)

    • • Seizures refractory to >2 antiepileptic medications

    • • CSF findings of inflammation

    • • MRI showing demyelination or inflammation (such as T2/FLAIR medial temporal hyperintensity)

    • • Systemic cancer within 5 years of neurological symptom onset

    +3 points: Faciobrachial dystonic seizures
    APE2 score ≥4 suggests possible AE /autoimmune psychosis:APE2 score ≥7 suggests probable or definite AE / autoimmune psychosis:
    Possible AE (Graus 2016)9 Rapid progression (<3 mo) of working memory deficits, altered mental status, or psychiatric symptoms, AND at least one of: • New focal CNS findings• Unexplained seizures• CSF pleocytosis (>5 WBCs/μL)• Characteristic signs of demyelination or inflammation on brain T2 MRI AND reasonable exclusion of alternative diagnosesPossible autoimmune psychosis (Pollak 2020)15 Rapid progression (<3 mo) of current psychotic symptoms, AND at least one of: • Current/recent tumor diagnosis• Movement disorder• Adverse response to antipsychotics (e.g., NMS)• Significant cognitive dysfunction• Decreased consciousness• Unexplained seizures• Autonomic dysfunctionAlso see Graus et al 20169 for diagnostic criteria for autoantibody-negative but probable AE and other encephalitis syndromes.Probable anti-NMDAR encephalitis9 Rapid progression (<3 mo) of at least four of (or at least three if +teratoma):• Behavioral or cognitive dysfunction• Speech dysfunction• Seizures• Movement disorder• Decreased level of consciousness• Autonomic dysfunction or central hypoventilationAND EEG abnormalities AND/OR CSF pleocytosis or oligoclonal bands Definite anti-NMDAR encephalitis,9 1+ symptom groups from “Probable,” AND serum and CSF IgG anti-GluN1 antibodies, or antibodies in serum with neuronal confirmatory tests Definite autoimmune limbic encephalitis9Rapid progression (<3 mo) of working memory deficits, seizures, or psychiatric symptoms suggesting limbic involvement AND bilateral medial temporal lobe abnormalities on brain T2 MRI AND EEG temporal lobe abnormalities AND/OR CSF pleocytosis AND reasonable exclusion of alternative diagnoses Probable autoimmune psychosis15 Criteria met for “Possible,” AND at least one of: • CSF pleocytosis (>5 WBCs/μL)• Bilateral medial temporal lobe abnormalities on brain T2 MRI AND/OR at least two of: • EEG abnormalities• CSF oligoclonal bands or increased IgG index• Serum anti-neuronal antibody AND reasonable exclusion of alternative diagnoses Definite autoimmune psychosis15 Criteria met for “Probable,” AND presence in CSF of IgG class anti-neuronal antibodies
PreviousNext
Back to top

In this issue

Journal of the American Academy of Psychiatry and the Law Online: 52 (2)
Journal of the American Academy of Psychiatry and the Law Online
Vol. 52, Issue 2
1 Jun 2024
  • Table of Contents
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in recommending The Journal of the American Academy of Psychiatry and the Law site.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The Evolving Standard of Care for Autoimmune Neuropsychiatric Illness
(Your Name) has forwarded a page to you from Journal of the American Academy of Psychiatry and the Law
(Your Name) thought you would like to see this page from the Journal of the American Academy of Psychiatry and the Law web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
The Evolving Standard of Care for Autoimmune Neuropsychiatric Illness
Cynthia He, Nathaniel Morris, Dale McNiel, Renee Binder
Journal of the American Academy of Psychiatry and the Law Online Jun 2024, 52 (2) 225-234; DOI: 10.29158/JAAPL.240033-24

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
The Evolving Standard of Care for Autoimmune Neuropsychiatric Illness
Cynthia He, Nathaniel Morris, Dale McNiel, Renee Binder
Journal of the American Academy of Psychiatry and the Law Online Jun 2024, 52 (2) 225-234; DOI: 10.29158/JAAPL.240033-24
del.icio.us logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Autoimmune Encephalitis and Psychosis
    • The Existing Standard of Care
    • Litigation in Autoimmune Encephalitis
    • An Uncertain Standard of Care
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Toward Aspirational Forensic Mental Health Practice
  • Ethics Challenges in Correctional Mental Health
  • Methamphetamine-Associated Psychosis and Criminal Responsibility
Show more Analysis and Commentary

Similar Articles

Keywords

  • autoimmune encephalitis
  • autoimmune psychosis
  • diagnosis
  • malpractice
  • neuropsychiatry
  • standard of care

Site Navigation

  • Home
  • Current Issue
  • Ahead of Print
  • Archive
  • Information for Authors
  • About the Journal
  • Editorial Board
  • Feedback
  • Alerts

Other Resources

  • Academy Website
  • AAPL Meetings
  • AAPL Annual Review Course

Reviewers

  • Peer Reviewers

Other Publications

  • AAPL Practice Guidelines
  • AAPL Newsletter
  • AAPL Ethics Guidelines
  • AAPL Amicus Briefs
  • Landmark Cases

Customer Service

  • Cookie Policy
  • Reprints and Permissions
  • Order Physical Copy

Copyright © 2025 by The American Academy of Psychiatry and the Law